TriMas Co. (NASDAQ:TRS – Get Free Report) Director Shawn Sedaghat purchased 249,597 shares of the business’s stock in a transaction on Friday, March 7th. The stock was purchased at an average cost of $23.83 per share, for a total transaction of $5,947,896.51. Following the acquisition, the director now owns 346,825 shares in the company, valued at approximately $8,264,839.75. The trade was a 256.71 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Shawn Sedaghat also recently made the following trade(s):
- On Monday, March 10th, Shawn Sedaghat bought 554,149 shares of TriMas stock. The shares were purchased at an average price of $24.07 per share, with a total value of $13,338,366.43.
TriMas Trading Down 0.7 %
Shares of NASDAQ TRS traded down $0.17 during midday trading on Tuesday, hitting $23.98. 359,588 shares of the company traded hands, compared to its average volume of 276,079. TriMas Co. has a 12-month low of $19.33 and a 12-month high of $28.51. The firm has a market cap of $973.18 million, a P/E ratio of 37.47 and a beta of 0.65. The stock has a 50-day moving average price of $23.58 and a 200 day moving average price of $25.07. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83.
TriMas Announces Dividend
Institutional Investors Weigh In On TriMas
Hedge funds have recently made changes to their positions in the company. Western Standard LLC raised its holdings in TriMas by 86.6% in the third quarter. Western Standard LLC now owns 169,069 shares of the industrial products company’s stock worth $4,316,000 after purchasing an additional 78,450 shares in the last quarter. Impax Asset Management Group plc grew its position in shares of TriMas by 216.4% in the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock worth $10,467,000 after buying an additional 280,431 shares during the period. Barclays PLC increased its stake in shares of TriMas by 341.3% in the 3rd quarter. Barclays PLC now owns 68,792 shares of the industrial products company’s stock worth $1,755,000 after acquiring an additional 53,203 shares in the last quarter. JPMorgan Chase & Co. lifted its position in TriMas by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock valued at $982,000 after acquiring an additional 1,227 shares during the period. Finally, Jane Street Group LLC grew its holdings in TriMas by 74.4% in the third quarter. Jane Street Group LLC now owns 82,621 shares of the industrial products company’s stock worth $2,109,000 after purchasing an additional 35,258 shares during the period. 99.42% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have commented on TRS shares. BWS Financial reaffirmed a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Friday, February 28th. StockNews.com upgraded TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th.
Check Out Our Latest Research Report on TRS
About TriMas
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading
- Five stocks we like better than TriMas
- Are Penny Stocks a Good Fit for Your Portfolio?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Health Care Stocks Explained: Why You Might Want to Invest
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.